Phenethyl Isothiocyanate Inhibits Proliferation and Induces Apoptosis in Pancreatic Cancer Cells In Vitro and in a MIAPaca2 Xenograft Animal Model

REFERENCES

• Hruban RH, Adsay NV, Albores-Saavedra J, Anver MR, Biankin AV, et al.: Pathology of genetically engineered mouse models of pancreatic exocrine cancer: consensus report and recommendations. Cancer Res 66, 95–106, 2006.
   PubMed Web of Science ®Google Scholar
• Hezel AF, Kimmelman AC, Stanger BZ, Bardeesy N, and Depinho RA: Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 20, 1218–1249, 2006.
   PubMed Web of Science ®Google Scholar
• Maitra A, Fukushima N, Takaori K, and Hruban RH: Precursors to invasive pancreatic cancer. Adv Anat Pathol 12, 81–91, 2005.
   PubMed Web of Science ®Google Scholar
• Siegel R, Naishadham D, and Jemal A: Cancer statistics, 2012. CA Cancer J Clin 62, 10–29
   PubMed Web of Science ®Google Scholar
• Yachida S, Jones S, Bozic I, Antal T, Leary R, et al.: Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature 467, 1114–1117, 2010.
   PubMed Web of Science ®Google Scholar
• Stan SD, Singh SV, and Brand RE: Chemoprevention strategies for pancreatic cancer. Nat Rev Gastroenterol Hepatol 7, 347–356, 2010.
   PubMed Web of Science ®Google Scholar
• Olsen GW, Mandel JS, Gibson1 RW, Wattenberg LW, and Schuman LM: A case-control study of pancreatic cancer and cigarettes, alcohol, coffee, and diet. Am J Public Health 79, 1016–1019, 1989.
   PubMed Web of Science ®Google Scholar
• Verhoeven DT, Goldbohm RA, van Poppel G, Verhagen H, and van den Brandt PA: Epidemiological studies on Brassica vegetables and cancer risk. Cancer Epidemiol Biomarkers Prev 5, 733–748, 1996.
   PubMed Web of Science ®Google Scholar
• Chan JM, Wang F, and Holly EA: Vegetable and fruit intake and pancreatic cancer in a population-based case-control study in the San Francisco bay area. Cancer Epidemiol Biomarkers Prev 14, 2093–2097, 2005.
   PubMed Web of Science ®Google Scholar
• Higdon JV, Delage B, Williams DE, and Dashwood RH: Cruciferous vegetables and human cancer risk: epidemiological evidence and mechanistic basis. Pharmacol Res 5, 224–236, 2007.
   Web of Science ®Google Scholar
• Silverman DT, Swanson CA, Gridley G, Wacholder S, Greenberg RS, et al.: Dietary and nutritional factors and pancreatic cancer: a case-control study based on direct interviews. J Natl Cancer Inst 90, 1710–1719, 1998.
   PubMed Web of Science ®Google Scholar
• Larsson SC, Hakansson N, Naslund I, Bergkvist L, and Wolk A: Fruit and vegetable consumption in relation to pancreatic cancer risk: a prospective study. Cancer Epidemiol Biomarkers Prev 15, 301–305, 2006.
   PubMed Web of Science ®Google Scholar
• Hecht SS: Inhibition of carcinogenesis by isothiocyanates. Drug Metab Rev 32, 395–411, 2000.
   PubMed Web of Science ®Google Scholar
• Hayes JD, Kelleher MO, and Eggleston IM: The cancer chemopreventive actions of phytochemicals derived from glucosinolates. Eur J Nutr 47( Suppl 2), 73–88, 2008.
   PubMed Web of Science ®Google Scholar
• Powolny AA, Bommareddy A, Hahm ER, Normolle DP, Beumer JH, et al.: Chemopreventative potential of the cruciferous vegetable constituent phenethyl isothiocyanate in a mouse model of prostate cancer. J Natl Cancer Inst 103, 571–584, 2011.
   PubMed Web of Science ®Google Scholar
• Cheung KL and Kong AN: Molecular targets of dietary phenethyl isothiocyanate and sulforaphane for cancer chemoprevention. AAPS J 12, 87–97, 2010.
   PubMed Web of Science ®Google Scholar
• Zhang Y: Cancer-preventive isothiocyanates: measurement of human exposure and mechanism of action. Mutat Res 555, 173–190, 2004.
   PubMed Web of Science ®Google Scholar
• Stan SD, Kar S, Stoner GD, and Singh SV: Bioactive food components and cancer risk reduction. J Cell Biochem 104, 339–356, 2008.
   PubMed Web of Science ®Google Scholar
• Xiao D, Powolny AA, Moura MB, Kelley EE, Bommareddy A, et al.: Phenethyl isothiocyanate inhibits oxidative phosphorylation to trigger reactive oxygen species-mediated death of human prostate cancer cells. J Biol Chem 285, 26558–26569, 2010.
   PubMed Web of Science ®Google Scholar
• Bommareddy A, Hahm ER, Xiao D, Powolny AA, Fisher AL, et al.: Atg5 regulates phenethyl isothiocyanate-induced autophagic and apoptotic cell death in human prostate cancer cells. Cancer Res 69, 3704–3712, 2009.
   PubMed Web of Science ®Google Scholar
• clinicaltrials.gov Identifiers: NCT00968461, NCT00005883, and NCT00691132. Retrieved from www.clinicaltrials.gov
   Google Scholar
• Nishikawa A, Furukawa F, Uneyama C, Ikezaki S, Tanakamaru, et al.: Chemopreventive effects of phenethyl isothiocyanate on lung and pancreatic tumorigenesis in N-nitrosobis(2-oxopropyl)amine-treated hamsters. Carcinogenesis 17, 1381–1384, 1996.
   PubMed Web of Science ®Google Scholar
• Stan SD, Zeng Y, and Singh SV: Ayurvedic medicine constituent withaferin A causes G2 and M phase cell cycle arrest in human breast cancer cells. Nutr Cancer 60(S1), 51–60, 2008.
   PubMed Web of Science ®Google Scholar
• Hendzel MJ, Wei Y, Mancini MA, Van Hooser A, Ranalli T, et al.: Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 106, 348–360, 1997.
   PubMed Web of Science ®Google Scholar
• Artavanis-Tsakonas S, Rand MD, and Lake RJ: Notch signaling: cell fate control and signal integration in development. Science 284, 770–776, 1999.
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Maitra A, Ghosh B, Zechner U, Argani P, et al.: Notch mediates TGF α-induced changes in epithelial differentiation during pancreatic tumorigenesis. Cancer Cell 3, 565–576, 2003.
   PubMed Web of Science ®Google Scholar
• Mysliwiec P and Boucher MJ: Targeting Notch signaling in pancreatic cancer patients—rationale for new therapy. Adv Med Sci 54, 136–142, 2009.
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Hosotani R, Wada M, Lee JU, Koshiba T, et al.: Immunohistochemical analysis of Bcl-2, Bax, Bcl-X, and Mcl-1 expression in pancreatic cancers. Oncology 56, 73–82, 1999.
   PubMed Web of Science ®Google Scholar
• Hinz S, Trauzold A, Boenicke L, Sandberg C, Beckmann S, et al.: Bcl-XL protects pancreatic adenocarcinoma cells against CD95-and TRAIL-receptor-mediated apoptosis. Oncogene 19, 5477–5486, 2000.
   PubMed Web of Science ®Google Scholar
• Friess H, Lu Z, Andren-Sandberg A, Berberat P, Zimmermann A, et al.: Moderate activation of the apoptosis inhibitor Bcl-xL worsens the prognosis in pancreatic cancer. Ann Surg 228, 780–787, 1998.
   PubMed Web of Science ®Google Scholar
• Gross A, McDonnell JM, and Korsmeyer SJ: Bcl-2 family members and the mitochondria in apoptosis. Genes Dev 13, 1899–1911, 1999.
   PubMed Web of Science ®Google Scholar
• Cain K, Brown DG, Langlais C, and Cohen GM: Caspase activation involves the formation of the aposome, a large (approximately 700 kDa) caspase-activating complex. J Biol Chem 274, 22686–22692, 1999.
   PubMed Web of Science ®Google Scholar
• Oliver FJ, de la Rubia G, Rolli V, Ruiz-Ruiz MC, de Murcia G, et al.: Importance of poly(ADP-ribose) polymerase and its cleavage in apoptosis. Lesson from an uncleavable mutant. J Biol Chem 273, 33533–33539, 1998.
   PubMed Web of Science ®Google Scholar
• Go MJ, Eastman DS, and Artavanis-Tsakonas S: Cell proliferation control by Notch signaling in Drosophila development. Development 125, 2031–2040, 1998.
   PubMed Web of Science ®Google Scholar
• Shelly LL, Fuchs C, and Miele L: Notch-1 inhibits apoptosis in murine erythroleukemia cells and is necessary for differentiation induced by hybrid polar compounds. J Cell Biochem 73, 164–175, 1999.
   PubMed Web of Science ®Google Scholar
• Rizzo P, Osipo C, Foreman K, Golde T, Osborne B, et al.: Rational targeting of Notch in cancer. Oncogene 27, 5124–5131, 2008.
   PubMed Web of Science ®Google Scholar
• Ferrara C, Tessari G, Poletti A, Giacon C, Meggiato T, et al.: Ki-67 and c-jun expression in pancreatic cancer: a prognostic marker? Oncol Rep 6, 1117–1122, 1999.
   PubMed Web of Science ®Google Scholar
• Stanton KJ, Sidner RA, Miller GA, Cummings OW, Schmidt CM, et al.: Analysis of Ki-67 antigen expression, DNA proliferative fraction, and survival in resected cancer of the pancreas. Am J Surg 186, 486–492, 2003.
   PubMed Web of Science ®Google Scholar
• Lebe B, Sagol O, Ulukus C, Coker A, Karademir S, et al.: The importance of cyclin D1 and Ki-67 expression on the biological behavior of pancreatic adenocarcinomas. Pathol Res Pract 200, 389–396, 2004.
   PubMed Web of Science ®Google Scholar
• Karamitopoulou E, Zlobec I, Tornillo L, Carafa V, Schaffner T, et al.: Differential cell cycle and proliferation marker expression in ductal pancreatic adenocarcinoma and pancreatic intraepithelial neoplasia (PanIN). Pathology 42, 229–234, 2010.
   PubMed Web of Science ®Google Scholar
• Aloysius MM, Hewavisenthi SJ, Bates TE, Rowlands BJ, Lobo DN, et al.: Predictive value of tumor proliferation indices in periampullary cancers: Ki-67, mitotic activity index (MI) and volume corrected mitotic index (M/V) using tissue microarrays. World J Surg 34, 2115–2121, 2010.
   PubMed Web of Science ®Google Scholar
• Dang CX, Han Y, Qin ZY, and Wang YJ: Clinical significance of expression of p21 and p53 proteins and proliferating cell nuclear antigen in pancreatic cancer. Hepatobiliary Pancreat Dis Int 1, 302–305, 2002.
   PubMedGoogle Scholar
• Ji Y, Kuo Y, and Morris ME: Pharmacokinetics of dietary phenethyl isothiocyanate in rats. Pharm Res 22, 1658–1666, 2005.
   PubMed Web of Science ®Google Scholar
• Zhang Y and Talalay P: Mechanism of differential potencies of isothiocyanates as inducers of anticarcinogenic Phase 2 enzymes. Cancer Res 58, 4632–4639, 1998.
   PubMed Web of Science ®Google Scholar
• Konsue N, Kirkpatrick J, Kuhnert N, King LJ, Ioannides C: Repeated oral administration modulates the pharmacokinetic behavior of the chemopreventive agent phenethyl isothiocyanate in rats. Mol Nutr Food Res 54, 426–432, 2010.
   PubMed Web of Science ®Google Scholar
• Ji Y and Morris ME: Determination of phenethyl isothiocyanate in human plasma and urine by ammonia derivatization and liquid chromatography-tandem mass spectrometry. Anal Biochem 323, 39–47, 2003.
   PubMed Web of Science ®Google Scholar
• Liebes L, Conaway CC, Hochster H, Mendoza S, Hecht SS, et al.: High-performance liquid chromatography-based determination of total isothiocyanate levels in human plasma: application to studies with 2-phenethyl isothiocyanate. Anal Biochem 291, 279–289, 2001.
   PubMed Web of Science ®Google Scholar
• Wang X, Govind S, Sajankila SP, Mi L, Roy R, et al.: Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin. Mol Nutr Food Res 55, 1572–1581, 2011.
   PubMed Web of Science ®Google Scholar
• Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, et al.: Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by β-phenylethyl isothiocyanate. Cancer Cell 10, 241–252, 2006.
   PubMed Web of Science ®Google Scholar